| Literature DB >> 18069663 |
Rachel Linger1, Darshna Dudakia, Robert Huddart, Kathy Tucker, Michael Friedlander, Kelly-Anne Phillips, David Hogg, Michael A S Jewett, Radka Lohynska, Gedske Daugaard, Stéphane Richard, Agnes Chompret, Dominique Stoppa-Lyonnet, Catherine Bonaïti-Pellié, Axel Heidenreich, Peter Albers, Edith Olah, Lajos Geczi, Istvan Bodrogi, Peter A Daly, Parry Guilford, Sophie D Fosså, Ketil Heimdal, Sergei A Tjulandin, Ludmila Liubchenko, Hans Stoll, Walter Weber, Lawrence Einhorn, Mary McMaster, Larissa Korde, Mark H Greene, Katherine L Nathanson, Victoria Cortessis, Douglas F Easton, D Timothy Bishop, Michael R Stratton, Elizabeth A Rapley.
Abstract
A base substitution in the mouse Dnd1 gene resulting in a truncated Dnd protein has been shown to be responsible for germ cell loss and the development of testicular germ cell tumors (TGCT) in the 129 strain of mice. We investigated the human orthologue of this gene in 263 patients (165 with a family history of TGCT and 98 without) and found a rare heterozygous variant, p. Glu86Ala, in a single case. This variant was not present in control chromosomes (0/4,132). Analysis of the variant in an additional 842 index TGCT cases (269 with a family history of TGCT and 573 without) did not reveal any additional instances. The variant, p. Glu86Ala, is within a known functional domain of DND1 and is highly conserved through evolution. Although the variant may be a rare polymorphism, a change at such a highly conserved residue is characteristic of a disease-causing variant. Whether it is disease-causing or not, mutations in DND1 make, at most, a very small contribution to TGCT susceptibility in adults and adolescents. (c) 2007 Wiley-Liss, Inc.Entities:
Mesh：
Substances：
Year: 2008 PMID： 18069663 PMCID： PMC3109865 DOI： 10.1002/gcc.20526
Source DB: PubMed Journal: Genes Chromosomes Cancer ISSN： 1045-2257 Impact factor: 5.006